Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

The vast majority of people who have a minimally invasive heart valve replacement procedure do not participate in recommended cardiac rehabilitation, a Michigan Medicine-led study finds.

A Michigan Medicine transplant specialist examines different ways of caring for patients with liver cancer.

University of Michigan Rogel Cancer Center researchers are unraveling its nuances, advancing enabling technologies, advocating for patients and figuring out how to ethically integrate this technology into clinical care.

Researchers at the University of Michigan have developed a model for studying one type of familial epilepsy, opening the door to understanding—and eventually targeting—the mechanisms that lead to the disorder and its associated fatalities.

The newest COVID vaccine was approved by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention in September and is rolling out in pharmacies and clinics across the country.

For the first time in more than 20 years, dozens of pediatric cardiologists, surgeons and other health professionals have come together to develop new guidelines intended to improve heart surgery care for this population of children and teens.

Michigan Medicine researchers have zeroed in on C. auris’ uncanny ability to stick to everything from skin to catheters and made a startling discovery.

A form of art therapy for one dad brings joy to patients across his child's floor, also in-patient receiving treatments.

Cancer screening guidelines increasingly factor in how long a person has left to live, to guide whether to continue or stop screening. A new poll explores older adults’ attitudes toward this approach.

Postpartum individuals are more likely to have medical debt than those who are pregnant, suggests a Michigan Medicine led study that evaluated collections among a statewide commercially insured cohort of 14,560 pregnant people and 12,157 people in the postpartum period.

Experts at Michigan Medicine are focusing on helping people with chronic pain, which is defined as pain that lasts more than three months.

The fast-acting postpartum pill offers more convenience than the postpartum depression infusion treatment, brexanolone (branded Zulresso), which has been available since 2019, but cost concerns remain. As with all mental health medications, zuranolone should be paired with psychosocial treatment to treat all factors contributing to the disease.

A Michigan Medicine team of experts seeks to identify the human genetic causes of MASLD, formerly called NAFLD

Advanced programs in healthcare equip doctors, nurses, and others with the skills and knowledge needed for successful careers in health. Explore how Michigan’s Clinician Scholars Program can empower healthcare innovators across different disciplines and enhance medical education.